✦ LIBER ✦

118 Risk adapted therapy in breast cancer based on molecular signature

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P58 Prospective risk adapted therapy of

✍ M. Buehner; M. Folger; V. Dresel; N. Lang; A.H. Tulusan 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 147 KB

‘Suspect molecular signature’ in blood a

✍ Debald, Manuel; Yeghiazaryan, Kristina; Cebioglu, Melanie; Kuhn, Walther; Schild 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 231 KB

Intrinsic molecular signature of breast

✍ Stefano Calza, Per Hall, Gert Auer, Judith Bjöhle, Sigrid Klaar… 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 237 KB

Familial risks in second primary breast

✍ K Hemminki; P Vaittinen 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Adjuvant systemic therapy for breast can

✍ Kerryn W. Reding; Jonine L. Bernstein; Bryan M. Langholz; Leslie Bernstein; Robe 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 188 KB

The impact of adjuvant therapy on contra

✍ Michael Schaapveld; Otto Visser; W. J. Louwman; Pax H. B. Willemse; Elisabeth G. 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 248 KB